Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus lidocaine for prevention of fentanyl-induced cough
IRCT20211023052848N1Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of dexmedetomidine, lidocaine and fentanyl in cough (3 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Cough incidence and Cough intensity. Started Nov 2021; status: completed.
02
Drugs
dexmedetomidinelidocainefentanyl
03
Conditions
cough
Beyond the preview
Go deeper on IRCT20211023052848N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211023052848N1.